EUDA Health Holdings Limited cash flow to debt ratio of -101.05% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

EUDA Health Holdings Limited's free cash flow has decreased 17.68% from $-2.15M last year to $-2.53M, signaling decreasing performance

EUDA Health Holdings Limited's debt to equity ratio is -0.56, signaling that the company spent its equity and risk bankruptcy.

EUDA Health Holdings Limited's debt to equity ratio is -0.56, signaling that the company spent its equity and risk bankruptcy.

EUDA Health Holdings Limited has negative EBITDA, making leverage ratio unreliable

EUDA Health Holdings Limited's interest coverage ratio is -15.73, which means that the company struggles to meet interest obligations, signaling financial risk.

EUDA Health Holdings Limited's profit margin has increased (-89.42%) in the last year from -382.87% to -40.49%, signaling increasing performance

EUDA Health Holdings Limited's short-term liabilities of $5.84M exceed its short-term assets of $1.04M, signaling financial risk

EUDA Health Holdings Limited's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

EUDA Health Holdings Limited's return on equity of 119.56%, is higher than 15.00%, indicating good performance

EUDA Health Holdings Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

EUDA Health Holdings Limited has insufficient public price history to evaluate earnings stability.

EUDA Health Holdings Limited has negative free cash flow, indicating the company is burning cash rather than generating it

EUDA Health Holdings Limited has negative free cash flow, indicating cash burn

EUDA Health Holdings Limited's yearly earnings has increased -81.94% since last year from $-15.36M to $-2.77M, signaling increasing performance

EUDA Health Holdings Limited's yearly revenue has increased 70.04% since last year from $4.01M to $6.82M, signaling increasing performance

ROIC 239.94% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

EUDA Health Holdings Limited's 3-year revenue CAGR of 21.91% is positive, indicating growing revenue over the past 3 years

EUDA Health Holdings Limited had revenue growth in only 2 out of 5 years, indicating inconsistent revenue performance

EUDA Health Holdings Limited has insufficient public price history to evaluate ROE consistency.

EUDA Health Holdings Limited has insufficient data to evaluate this check.

EUDA Health Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

EUDA Health Holdings Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

EUDA Health Holdings Limited has negative or missing EBITDA, making EV/EBITDA ratio unreliable

EUDA Health Holdings Limited has insufficient data to evaluate this check.

EUDA Health Holdings Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

EUDA Health Holdings Limited has negative shareholder equity; price-to-book is not meaningful and the check fails

EUDA Health Holdings Limited has a price-to-sales ratio of 2.35x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue